Hedge funds run by legendary names like Nelson Peltz and David Tepper make billions of dollars a year for themselves and their super-rich accredited investors (you’ve got to have a minimum of $1 million liquid to invest in a hedge fund) by spending enormous resources on analyzing and uncovering data about small-cap stocks that the big brokerage houses don’t follow. Small caps are where they can generate significant out-performance. These stocks have been on a tear since the end of June, outperforming large-cap index funds by more than 10 percentage points. That’s why we pay special attention to hedge fund activity in these stocks.
Is Endo International plc – Ordinary Shares (NASDAQ:ENDP) the right pick for your portfolio? Prominent investors are turning less bullish. The number of long hedge fund positions retreated by 4 recently. ENDP was in 32 hedge funds’ portfolios at the end of September. There were 36 hedge funds in our database with ENDP positions at the end of the previous quarter. The level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity but it may still be less popular than similarly priced stocks. That’s why at the end of this article we will examine companies such as First Niagara Financial Group Inc. (NASDAQ:FNFG), American Capital Ltd. (NASDAQ:ACAS), and Regal Entertainment Group (NYSE:RGC) to gather more data points.
Follow Endo Health Solutions Inc. (NASDAQ:ENDP)
Follow Endo Health Solutions Inc. (NASDAQ:ENDP)
At Insider Monkey, we’ve developed an investment strategy that has delivered market-beating returns over the past 12 months. Our strategy identifies the 100 best-performing funds of the previous quarter from among the collection of 700+ successful funds that we track in our database, which we accomplish using our returns methodology. We then study the portfolios of those 100 funds using the latest 13F data to uncover the 30 most popular mid-cap stocks (market caps of between $1 billion and $10 billion) among them to hold until the next filing period. This strategy delivered 18% gains over the past 12 months, more than doubling the 8% returns enjoyed by the S&P 500 ETFs.
![medication, pharmacist, shelf, care, pharmaceutical, medical, day, drug, clinic, medicament, drugstore, treatment, ill, smiling, medicine, pharmaceutics, of, hospital,](https://imonkey-blog.imgix.net/blog/wp-content/uploads/2016/01/04033940/shutterstock_256151683-750x500.jpg?auto=fortmat&fit=clip&expires=1755993600&width=480&height=320)
wavebreakmedia/Shutterstock.com
What have hedge funds been doing with Endo International plc – Ordinary Shares (NASDAQ:ENDP)?
At the end of the third quarter, a total of 32 of the hedge funds tracked by Insider Monkey were long this stock, a decline of 11% from one quarter earlier, and the fourth-straight quarter with declining hedge fund ownership of the stock. With hedgies’ sentiment swirling, there exists a few notable hedge fund managers who were boosting their holdings meaningfully (or already accumulated large positions).
According to publicly available hedge fund and institutional investor holdings data compiled by Insider Monkey, John Paulson’s Paulson & Co has the most valuable position in Endo International plc – Ordinary Shares (NASDAQ:ENDP), worth close to $160.3 million, corresponding to 1.7% of its total 13F portfolio. The second most bullish fund manager is Larry Robbins of Glenview Capital, with an $85.7 million position. Remaining peers with similar optimism comprise Stephen DuBois’ Camber Capital Management, Malcolm Fairbairn’s Ascend Capital, and Zach Schreiber’s Point State Capital.